Skip to main content
    V

    Viemed Healthcare Inc (VMD)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $9.15
    -0.02 (-0.22%)

    Market Cap: $347.48M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Viemed Healthcare Inc (VMD) P/E Ratio & Valuation History

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Viemed Healthcare (VMD) trades at 24.1x trailing earnings and 1.1x sales. Its P/E of 24.1x is below its 5-year median of 26.2x. Its forward P/E is 19.3x. The median P/E across 6 similar companies is 25.7x.

    Current Multiples

    Its forward P/E is below its trailing P/E, which implies earnings per share about 24.9% higher over the next year. Its free cash flow yield is 6.1%.

    MultipleValue
    P/E (trailing)24.1x
    Forward P/E19.3x
    Price to sales1.1x
    Price to book2.3x
    EV/EBITDA6.2x
    Price to FCF16.3x
    EV/FCF16.1x
    PEG1.9
    FCF yield6.1%
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 45.0% below 2.0x and its P/B is 25.8% below 3.1x.

    MultipleCurrent5-year median10-year median
    P/E24.1x26.2xN/A
    P/S1.1x1.5x2.0x
    P/B2.3x2.5x3.1x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 105 months (10-year).

    Valuation History

    Over the 8 year ends shown, its P/E ranged from 9.9x in 2020 to 50.4x in 2022.

    Year endPriceP/EP/SP/B
    2025$7.4320.1x1.1x2.1x
    2024$8.0224.7x1.4x2.5x
    2023$7.8529.1x1.7x2.8x
    2022$7.5650.4x2.1x3.1x
    2021$5.2223.7x1.8x2.2x
    2020$7.769.9x2.3x3.9x
    2019$6.2027.0x3.0x5.7x
    2018$3.8016.5x2.3x4.3x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About VMD

    What is VMD's forward P/E ratio?

    Viemed Healthcare has a forward P/E ratio of 19.3x.

    Is VMD stock overvalued?

    GNG's valuation label for VMD is Undervalued. Its P/E of 24.1x compares with a median of 25.7x across 6 similar companies.

    What is VMD's price to sales ratio?

    Viemed Healthcare has a price to sales ratio of 1.1x.

    What is Viemed Healthcare's average P/E ratio over 5 years?

    Viemed Healthcare's median P/E over the last 5 years is 26.2x, from 60 month-end values through Oct 2026.

    What is VMD's PEG ratio?

    Viemed Healthcare has a PEG ratio of 1.9.